Insight Molecular Diagnostics (IMDX) Construction in Progress (2019 - 2026)
Insight Molecular Diagnostics (IMDX) posted Construction in Progress of $471000.0 for Q1 2026, down 38.43% sequentially from $765000.0 in Q4 2025, and up 30.83% YoY from $360000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Construction in Progress (2019 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Construction in Progress for 8 years, with the latest figure at $471000.0 in Q1 2026.
- Quarterly Construction in Progress rose 30.83% year-over-year to $471000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $471000.0 (up 30.83% YoY) and the FY2025 annual result came in at $765000.0, up 125.0% from the prior year.
- Construction in Progress retreated to $471000.0 in Q1 2026 per IMDX's latest filing, from $765000.0 in the prior quarter.
- Over five years, Construction in Progress peaked at $3.1 million in Q1 2022 and troughed at $263000.0 in Q2 2025.
- A 5-year average of $997117.6 and a median of $685000.0 in 2025 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2022 and 2023: Construction in Progress soared 730.52% in 2022, then tumbled 81.87% in 2023.
- Over 5 years, Construction in Progress stood at $2.1 million in 2022, then tumbled by 66.07% to $726000.0 in 2023, then plunged by 53.17% to $340000.0 in 2024, then soared by 125.0% to $765000.0 in 2025, then slumped by 38.43% to $471000.0 in 2026.
- According to Business Quant data, Construction in Progress over the past three periods registered $471000.0, $765000.0, and $685000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | 471,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 471,000.00 |
| Dec 31, 2025 | 765,000.00 |
| Sep 30, 2025 | 685,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 340,000.00 |
| Sep 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 518,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.86 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 285,000.00 |
| Jun 30, 2021 | 344,000.00 |